tirzepatide obstructive sleep apnea fda approval 2024 Zepbound (tirzepatide) is now FDA-approved as the first medication for (OSA) in adults with obesity. It works by reducing body weight, which helps improve breathing during Breakthrough Treatment for Obstructive Sleep

Mol Cell Endocrinol , 198(1-2):8995

(3) Its easy to understand why many people see growth hormone therapy as the fountain of youth

Most patients report the experience as manageable with proper technique and preparation

People taking GLP-1 medications may experience a range of positive effects: Lower blood sugar levels, leading to improved diabetes control Promote weight loss, which can improve overall health and lower the risk of related medical problems Lower the risk of heart attacks, strokes, and kidney disease in people with diabetes or those at high cardiovascular risk Improve liver health in people with metabolic dysfunction-associated steatotic liver disease (MASLD) Help lower blood pressure and cholesterol, supporting overall heart health Reduce appetite and food cravings, making healthy eating patterns easier to maintain Less likely than some other diabetes medicines to cause low blood sugar or unwanted weight gain Can provide meaningful and lasting results for people who have struggled to lose weight with lifestyle changes alone Are there specific lifestyle changes that work best with these medications

Data from the agency's Adverse Event Reporting System (FAERS) shows more than 280 of those were associated with compounded drugs said to contain semaglutide, although the figure may be an undercount because some reports were submitted by patients who may not recognize or report that their medicine is a compounded drug